Stratview Research has recently published a report on the Synthetic Biology Market. This strategically evaluated report provides a detailed overview that presents today's market scenario and future possibilities, as well as market intelligence and information, for a 5-year period from 2022 to 2028
Synthetic Biology Market Analysis:
Stratview Research’s report discusses the segment-wise current market condition. Also, it offers an estimation of future growth opportunities. As per the estimation, the Synthetic Biology Market is estimated to grow from USD 12.1 billion in 2022 to USD 43.9 billion by 2028 at a healthy CAGR of 23.9% during the forecast 2022-2028.
Some of the companies drives the market growth:
- Agilent Technologies, Inc.,
- Amyris, Inc.,
- Codexis, Inc.,
- Creative Enzymes,
- Cyrus Biotechnology Inc.,
- Eurofins Scientific,
- GenScript Biotech Corporation,
- Ginkgo Bioworks,
- Integrated DNA Technologies, Inc.,
- New England Biolabs,
- Novozymes A/S,
- Precigen, Inc.,
- Synthego Corporation,
- Synthetic Genomics, Inc.,
- The Merck Group,
- Thermo Fisher Scientific Inc.,
- Twist Bioscience.
To download a free sample of the report, Click Here: https://www.stratviewresearch.com/Request-Sample/846/synthetic-biology-market.html#form
Segment Analysis
By Tool Type
The market is segmented as oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides & synthetic DNA segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period.
By Technology Type
The synthetic biology market is segmented as gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement & modeling, microfluidics, and nanotechnology.
By End-Use Industry Type
The market is segmented as medical, industrial, food & agriculture, and environmental. The medical segment is expected to grow at the highest rate in the market over the forecast period
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
